MacroGenics (MGNX)
(Delayed Data from NSDQ)
$3.28 USD
-0.11 (-3.25%)
Updated Sep 20, 2024 04:00 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Average Brokerage Rating
Current ABR | 2.17 |
ABR (Last week) | 2.27 |
# of Recs in ABR | 12 |
Average Target Price | $7.44 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 63 of 253 |
Current Quarter EPS Est: | 0.08 |
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 4 | 4 | 7 | 7 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 7 | 7 | 7 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.17 | 2.27 | 2.27 | 1.73 | 1.73 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/16/2024 | Cowen & Co. | Tara Bancroft | Hold | Hold |
9/16/2024 | Evercore Partners | Research Department | Not Available | Strong Buy |
9/16/2024 | Not Identified | Not Identified | Hold | Hold |
8/15/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/1/2024 | BTIG | Kaveri Pohlman | Strong Buy | Hold |
8/1/2024 | H.C. Wainwright & Co. | Robert Burns | Hold | Hold |
7/31/2024 | Guggenheim Securities | Michael Schmidt | Strong Buy | Hold |
7/31/2024 | JMP Securities | Silvan C Tuerkcan | Strong Buy | Strong Buy |
7/31/2024 | B. Riley Securities | Mayank Mamtani | Hold | Hold |
7/30/2024 | SVB Securities | Jonathan W Chang | Strong Buy | Strong Buy |
7/29/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/10/2024 | BMO Capital Markets | Etzer Darout | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.